Ampio Pharmaceuticals Inc. (AMPE)

tablet, chart, ipad, man, bloomberg, business, stock, people, touch, hand, market, buy, course, app, notebook, schedule, bank, plastic, editorial, technology, computer, actions, mobile, currency, electronic, payment, purchase, background, device, online, statistic, exchange, shares, pay, holder, display, transaction, interface, illustrative, internet, commercial, finance, gadget, card, hold, e-commerce, macbook, money, terminal, apple, office, banking, wallet

Hedge Fund and Insider Trading News: David Einhorn, Ken Fisher, Tom Steyer, Jim Simons, QAD Inc. (QADA), Chesapeake Energy Corporation (CHK), and More

Ken Fisher Has a Side Bet on a Risky Corner of Wall Street (Bloomberg) Billionaire Ken Fisher made his name and fortune picking stocks. But over the years...

Keep Reading →

November 8 - Hedge Funds, Insider Trading - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Answering Two Most Important Questions Surrounding Ampio Pharmaceuticals Inc (AMPE)

Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) has recently reported topline from its PIVOT trial and the stock lost over 60% on the announcement last Thursday...

Keep Reading →

July 5 - News, Stock Analysis - Comments

Here’s Why Traders Are Buzzing Around Lions Gate, Stellar Biotechnologies, and Three Other Stocks

Stocks are trading in the green on Thursday as markets continue to steadily recover from the Brexit-triggered wild swings. However, investors remain selective...

Keep Reading →

June 30 - Market Movers, News - Comments

Trellus Management’s Top Biotech Stock Picks For Q4

Trellus Management is a New York-based long/short equity hedge fund founded by Adam Usdan in 1994. The fund manages client focused equity portfolios and...

Keep Reading →

November 4 - Hedge Fund Analysis, Hedge Funds, News - Comments

Hi-Shakers News: Ampio Pharmaceuticals Inc (AMPE) Climbs, YY Inc (ADR) (YY) Added to Watch List, Sandstorm Gold Ltd. (SAND) Deal with Premier Royalty

Editor’s Note: Ampio Pharmaceuticals Inc (NYSEMKT:AMPE), YY Inc (ADR) (NASDAQ:YY), Sandstorm Gold Ltd. (NYSEMKT:SAND) Ampio climbs on study of...

Keep Reading →

August 19 - News - Comments

Roche Holding Ltd. (ADR) (RHHBY), Novartis AG (ADR) (NVS): Should You Keep an Eye on These Eye Treatment Biotechs?

Investors might want to keep their eyes on the eye care industry, as the battle for eye treatments heats up across the biotech sector. Two eye diseases...

Keep Reading →

August 8 - News - Comments

AcelRx Pharmaceuticals Inc (ACRX): Insiders Are Buying, Should You?

Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a first-rate investment today? Hedge funds are getting less optimistic. The number of long hedge fund bets...

Keep Reading →

June 26 - News - Comments

Regeneron Pharmaceuticals Inc (REGN): Is This Eye Drug Worth The Hype?

Editor’s Note: The original article incorrectly references Lucentis’ and Eylea’s dosage instructions and Roche’s vaccine market share. This...

Keep Reading →

June 21 - News - Comments

Regeneron Pharmaceuticals Inc (REGN): Is This Eye Drug Worth The Hype?

Editor’s Note: The original article incorrectly references Lucentis’ and Eylea’s dosage instructions. This has been corrected and Motley Fool sincerely...

Keep Reading →

June 18 - News - Comments

Hedge Funds Are Betting On Horizon Pharma Inc (HZNP)

Is Horizon Pharma Inc (NASDAQ:HZNP) going to take off soon? Money managers are turning bullish. The number of long hedge fund bets improved by 1 recently...

Keep Reading →

June 17 - News - Comments

Regeneron Pharmaceuticals Inc (REGN), Ampio Pharmaceuticals, Inc. (AMPE): Is This Eye Drug Worth The Hype?

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) should spike– every time there’s a slight pullback the stock shoots higher. Last Thursday Regeneron gained...

Keep Reading →

June 17 - News - Comments

Hedge Funds Are Crazy About Zogenix, Inc. (ZGNX)

Is Zogenix, Inc. (NASDAQ:ZGNX) a healthy stock for your portfolio? Hedge funds are betting on the stock. The number of long hedge fund positions rose...

Keep Reading →

April 15 - News - Comments

Posts Tagged ‘Ampio Pharmaceuticals Inc. (AMPE)’